Skip to Main Content

Paper Details

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
J Clin Oncol
4
2023
CDK4, CDK4/6, Hormone Receptor, Hormone Receptor-Positive Breast Cancer, Neutropenia, Palbociclib, Patients, breast cancer, neutropenia, obese, overweight, palbociclib, patients, underweight
Author NameAffiliation
Claudine IsaacsGeorgetown University
Justin M BalkoVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Fatima CardosoChampalimaud Clinical Center/Champalimaud Foundation
Matthew P GoetzMayo Clinic
Barbro LinderholmSahlgrenska University Hospital
Barbro LinderholmInstitution of Clinical Sciences, Gothenburg University
Lois ShepherdQueen's University
Eric P WinerYale Cancer Center, Yale University
Antonio C WolffJohns Hopkins University
Gabriele ZoppoliGruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Universita degli Studi di Genova
Gabriele ZoppoliIRCCS Ospedale Policlinico San Martino
Gabriele ZoppoliGruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Universita degli Studi di Genova
Gabriele ZoppoliIRCCS Ospedale Policlinico San Martino
  • 1 - 13

Datasets

Release 1.2